Institutional
Venrock Adviser, LLC
CIK 0001615982
$2.68B
Reported AUM
33
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $714.9M | 26.68% | — | HELD |
| 2 | ERAS | ERASCA INC | $265.1M | 9.89% | -1,474,271 | -8.3% |
| 3 | ORKA | ORUKA THERAPEUTICS INC | $203.5M | 7.60% | — | HELD |
| 4 | SYRE | SPYRE THERAPEUTICS INC | $185.9M | 6.94% | — | HELD |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | $130.3M | 4.86% | -254,500 | -3.8% |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $99.0M | 3.70% | +180,000 | +18.0% |
| 7 | DMRA | DAMORA THERAPEUTICS INC | $93.3M | 3.48% | +3,603,595 | NEW |
| 8 | OCUL | OCULAR THERAPEUTIX INC | $87.6M | 3.27% | +3,031,379 | +41.4% |
| 9 | COGT | COGENT BIOSCIENCES INC | $77.0M | 2.87% | — | HELD |
| 10 | VRDN | VIRIDIAN THERAPEUTICS INC | $75.9M | 2.83% | — | HELD |
| 11 | SVRA | SAVARA INC | $75.0M | 2.80% | — | HELD |
| 12 | ELVN | ENLIVEN THERAPEUTICS INC | $67.7M | 2.53% | -1,500,000 | -46.5% |
| 13 | ORIC | ORIC PHARMACEUTICALS INC | $54.7M | 2.04% | -1,356,465 | -23.9% |
| 14 | VOR | VOR BIOPHARMA INC | $54.3M | 2.03% | +1,097,953 | +56.5% |
| 15 | MAZE | MAZE THERAPEUTICS INC | $47.8M | 1.78% | +53,465 | +3.5% |
| 16 | CTMX | CYTOMX THERAPEUTICS INC | $46.9M | 1.75% | -5,579,376 | -35.9% |
| 17 | JBIO | JADE BIOSCIENCES INC | $45.2M | 1.69% | — | HELD |
| 18 | DYN | DYNE THERAPEUTICS INC | $39.4M | 1.47% | — | HELD |
| 19 | CBIO | CRESCENT BIOPHARMA INC. | $39.2M | 1.46% | — | HELD |
| 20 | ZURA | ZURA BIO LTD | $38.3M | 1.43% | +1,089,875 | +20.4% |
| 21 | RLMD | RELMADA THERAPEUTICS INC | $33.7M | 1.26% | +4,843,380 | NEW |
| 22 | — | ENGENE HOLDINGS INC | $32.5M | 1.21% | — | HELD |
| 23 | TENX | TENAX THERAPEUTICS INC | $26.8M | 1.00% | +1,675,262 | NEW |
| 24 | ANL | ADLAI NORTYE LTD | $22.2M | 0.83% | +3,212,731 | NEW |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $19.7M | 0.73% | +8,695,652 | NEW |
| 26 | CGEM | CULLINAN THERAPEUTICS INC | $19.6M | 0.73% | — | HELD |
| 27 | HELP | CYBIN INC | $18.5M | 0.69% | +11,404 | +0.3% |
| 28 | SRZN | SURROZEN INC | $18.4M | 0.69% | — | HELD |
| 29 | SEPN | SEPTERNA INC | $12.2M | 0.45% | -104,752 | -17.1% |
| 30 | KRRO | KORRO BIO INC | $11.4M | 0.43% | +1,009,500 | NEW |
| 31 | ANRO | ALTO NEUROSCIENCE INC | $11.2M | 0.42% | +500,000 | NEW |
| 32 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $10.4M | 0.39% | — | HELD |
| 33 | XFOR | X4 PHARMACEUTICALS INC | $1.4M | 0.05% | +330,525 | NEW |
| 34 | UPB | UPSTREAM BIO INC | — | — | -1,169,298 | EXITED |
| 35 | CASIF | CASI PHARMACEUTICALS INC | — | — | -987,259 | EXITED |
Source: SEC EDGAR · accession 0001615982-26-000011. 13F discloses long positions only — shorts, foreign equities, and options are excluded.